Effects of ascending buprenorphine (cas 136232-82-1) doses on measures of experimental pain: A pilot study
-
Add time:08/31/2019 Source:sciencedirect.com
Backgroundbuprenorphine (cas 136232-82-1) is widely used in the treatment of opioid use disorder and pain management. Little is known about the analgesic effects of high-dose sublingual buprenorphine, particularly in doses of >8 mg. The aim of this study was to examine the effect of ascending doses of buprenorphine upon acute pain measures in patients stabilized on buprenorphine as treatment for opioid dependence.
We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers
Prev:buprenorphine (cas 136232-82-1) in the United States: Motives for abuse, misuse, and diversion
Next:Full length articleUnderstanding the use of diverted buprenorphine (cas 136232-82-1)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short CommunicationPerceived need and availability of psychosocial interventions across buprenorphine (cas 136232-82-1) prescriber specialties09/07/2019
- Epidemiology of severe buprenorphine (cas 136232-82-1) exposures reported to the U.S. Poison Centers09/06/2019
- A comparison of buprenorphine (cas 136232-82-1) and psychosocial treatment outcomes in psychosocial and medical settings09/05/2019
- Review articleTransdermal buprenorphine (cas 136232-82-1) patch: Potential for role in management of opioid dependence09/04/2019
- Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion09/03/2019
- Evaluation of an emergency department buprenorphine (cas 136232-82-1) induction and medication-assisted treatment referral program09/02/2019
- Full length articleUnderstanding the use of diverted buprenorphine (cas 136232-82-1)09/01/2019
- buprenorphine (cas 136232-82-1) in the United States: Motives for abuse, misuse, and diversion08/30/2019
- Full length articleMaternal buprenorphine (cas 136232-82-1) treatment during pregnancy and maternal physiology08/29/2019
